inclusion sont fondés sur les critères de Porto édités par l'ESPGHAN (82) Deux groupes distincts sont constitués : ? le groupe des RCH dites classiques (RCHC) ,
Pediatric ulcerative colitis associated with autoimmune diseases: A distinct form of inflammatory bowel disease?, Inflammatory Bowel Diseases, vol.111, issue.10, pp.1809-1826, 2012. ,
DOI : 10.1067/mai.2003.3
Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data, Gut, vol.58, issue.11, pp.1490-1497, 2009. ,
DOI : 10.1136/gut.2009.188383
Epidemiology of inflammatory bowel diseases: New insights from a French population-based registry (EPIMAD), Digestive and Liver Disease, vol.45, issue.2, pp.89-94, 2013. ,
DOI : 10.1016/j.dld.2012.09.005
URL : https://hal.archives-ouvertes.fr/hal-01701899
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee, The American Journal of Gastroenterology, vol.4, issue.3, pp.501-524, 2010. ,
DOI : 10.1016/0016-5085(92)90831-I
Genetics of childhood-onset inflammatory bowel disease, Inflammatory Bowel Diseases, vol.45, issue.1, pp.346-61, 2011. ,
DOI : 10.1016/j.freeradbiomed.2008.03.003
Is pediatric IBD treatment different than in adults, Minerva Gastroenterol Dietol, vol.58, pp.137-50, 2012. ,
Genetic Determinants of Pediatric Inflammatory Bowel Disease: Is Age of Onset Genetically Determined?, Digestive Diseases, vol.27, issue.3, pp.236-245, 2009. ,
DOI : 10.1159/000228555
The Natural History of Pediatric Ulcerative Colitis: A Population-Based Cohort Study, The American Journal of Gastroenterology, vol.9, issue.8, pp.2080-2088, 2009. ,
DOI : 10.1053/gast.1997.v112.pm9178675
Inflammatory Bowel Diseases: the genetic revolution, Gastroent??rologie Clinique et Biologique, vol.33, pp.123-153, 2009. ,
DOI : 10.1016/S0399-8320(09)73147-1
Genetics of ulcerative colitis, Inflammatory Bowel Diseases, vol.7, issue.3, pp.831-879, 2011. ,
DOI : 10.1038/nri2097
Inflammatory Bowel Disease, New England Journal of Medicine, vol.361, issue.21, pp.2066-78, 2009. ,
DOI : 10.1056/NEJMra0804647
HLA-DRB1 Alleles May Influence Disease Phenotype in Patients With Inflammatory Bowel Disease: A Critical Reappraisal With Review of the Literature, Diseases of the Colon & Rectum, vol.48, issue.1, pp.57-64, 2005. ,
DOI : 10.1007/s10350-004-0747-0
HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis, Gut, vol.45, issue.3, pp.395-401, 1999. ,
DOI : 10.1136/gut.45.3.395
Appendectomy, smoking habits and the risk of developing ulcerative colitis: a case control study in private practice setting, Gastroent??rologie Clinique et Biologique, vol.31, issue.5, pp.493-500, 2007. ,
DOI : 10.1016/S0399-8320(07)89417-6
Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission, Inflammatory Bowel Diseases, vol.48, issue.3, pp.481-489, 2013. ,
DOI : 10.1038/ismej.2011.109
Microbiota of De-Novo Pediatric IBD: Increased Faecalibacterium Prausnitzii and Reduced Bacterial Diversity in Crohn's But Not in Ulcerative Colitis, The American Journal of Gastroenterology, vol.19, issue.12, 2012. ,
DOI : 10.1128/AEM.66.5.2263-2266.2000
Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease, Expert Review of Clinical Immunology, vol.2, issue.2, pp.161-169, 2012. ,
DOI : 10.1159/000262276
Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases, Gastroenterology, vol.140, issue.6, pp.1756-67, 2011. ,
DOI : 10.1053/j.gastro.2011.02.016
Management of Pediatric Ulcerative Colitis, Journal of Pediatric Gastroenterology and Nutrition, vol.55, issue.3, pp.340-61, 2012. ,
DOI : 10.1097/MPG.0b013e3182662233
Acute severe ulcerative colitis in children: A systematic review, Inflammatory Bowel Diseases, vol.37, issue.1, pp.440-449, 2011. ,
DOI : 10.1097/00005176-200408000-00008
P0721 FECAL CALPROTECTIN AS A MARKER OF INTESTINAL INFLAMMATION IN CHILDREN WITH IBD, THROUGH EVOLUTIONARY STAGES AND UNDER TREATMENT., Journal of Pediatric Gastroenterology and Nutrition, vol.39, issue.Supplement 1, p.331, 2004. ,
DOI : 10.1097/00005176-200406001-00845
Fecal Markers: Calprotectin and Lactoferrin, Gastroenterology Clinics of North America, vol.41, issue.2, pp.483-95, 2012. ,
DOI : 10.1016/j.gtc.2012.01.007
Mucosal healing, Acta Endoscopica, vol.18, issue.SupplIII, pp.123-131, 2013. ,
DOI : 10.1002/ibd.22917
Mucosal healing in inflammatory bowel diseases: a systematic review, Gut, vol.61, issue.11, pp.1619-1654, 2012. ,
DOI : 10.1136/gutjnl-2012-302830
Importance of mucosal healing in ulcerative colitis, Inflammatory Bowel Diseases, vol.55, issue.2, pp.338-384, 2010. ,
DOI : 10.1136/gut.2005.081794
Mucosal healing in inflammatory bowel disease: Treatment efficacy and predictive factors, Digestive and Liver Disease, vol.45, issue.12, pp.978-85, 2013. ,
DOI : 10.1016/j.dld.2013.07.006
Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study, Gastroenterology, vol.133, issue.2 ,
DOI : 10.1053/j.gastro.2007.05.029
evaluation and application of a pediatric ulcerative colitis activity index (PUCAI) -153p, Th : Philisophy, 2008. ,
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis, New England Journal of Medicine, vol.353, issue.23, pp.2462-76, 2005. ,
DOI : 10.1056/NEJMoa050516
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS), Gut, vol.61, issue.4, pp.535-577, 2012. ,
DOI : 10.1136/gutjnl-2011-300486
Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease, Inflammatory Bowel Diseases, vol.5, issue.9, pp.1598-619, 2010. ,
DOI : 10.1016/j.cgh.2006.10.021
Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm., Gut, vol.35, issue.1, pp.84-93, 1994. ,
DOI : 10.1136/gut.35.1.84
Liver histology and follow up of 68 patients with ulcerative colitis and normal liver function tests., Gut, vol.31, issue.4, pp.468-72, 1990. ,
DOI : 10.1136/gut.31.4.468
Atteintes pancr??atiques dans les maladies inflammatoires du tube digestif de l???enfant, Archives de P??diatrie, vol.9, issue.5, pp.469-77, 2002. ,
DOI : 10.1016/S0929-693X(01)00828-4
The Characteristics of Ulcerative Colitis Associated With Autoimmune Pancreatitis, Journal of Clinical Gastroenterology, vol.47, issue.6, pp.520-525, 2013. ,
DOI : 10.1097/MCG.0b013e31827fd4a2
Inflammatory bowel disease in the setting of autoimmune pancreatitis, Inflammatory Bowel Diseases, vol.2, issue.9, pp.1326-1356, 2009. ,
DOI : 10.2307/3002000
Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel Disease, Drugs, vol.103, issue.9, pp.2333-2382, 2012. ,
DOI : 10.1111/j.1572-0241.2008.02052.x
Joint involvement in chronic inflammatory bowel disease--current diagnostics and treatment options ,
Arthritic manifestations of inflammatory bowel disease, Am J Gastroenterol, vol.83, pp.703-712, 1988. ,
Musculoskeletal manifestations in inflammatory bowel disease, European Journal of Internal Medicine, vol.11, issue.4, pp.210-214, 2000. ,
DOI : 10.1016/S0953-6205(00)00093-5
Pulmonary diseases associated with inflammatory bowel diseases, Journal of Crohn's and Colitis, vol.14, issue.Suppl 2, pp.384-393, 2010. ,
DOI : 10.1002/ibd.20519
Significance of Erythema Nodosum and Pyoderma Gangrenosum in Inflammatory Bowel Diseases, Medicine, vol.87, issue.5, pp.281-93, 2008. ,
DOI : 10.1097/MD.0b013e318187cc9c
URL : https://hal.archives-ouvertes.fr/hal-00944425
Cutaneous Manifestations in Patients With Inflammatory Bowel Diseases, Inflammatory Bowel Diseases, vol.157, issue.1, pp.213-240, 2014. ,
DOI : 10.1111/j.1365-2133.2007.08048.x
Biological therapy for dermatological manifestations of inflammatory bowel disease, World Journal of Clinical Cases, vol.1, issue.2, pp.74-82, 2013. ,
DOI : 10.1001/archderm.143.2.223
Neurologic Aspects of Inflammatory Bowel Disease, Neurology, vol.45, issue.3, pp.416-437, 1995. ,
DOI : 10.1212/WNL.45.3.416
Primary sclerosing cholangitis: Summary of a workshop, Hepatology, vol.6, issue.3, pp.746-64, 2006. ,
DOI : 10.1016/0016-5085(94)90610-6
Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis, The American Journal of Gastroenterology, vol.35, issue.11, pp.3195-3204, 2000. ,
DOI : 10.1016/S0140-6736(75)91560-3
Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease, European Journal of Pediatrics, vol.35, issue.5, pp.575-83, 2009. ,
DOI : 10.1007/s00431-008-0798-7
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis, Gut, vol.54, issue.1, pp.91-97, 2005. ,
DOI : 10.1136/gut.2004.046615
Comparative Tolerability of Treatments for Inflammatory Bowel Disease, Drug Safety, vol.126, issue.1, pp.429-477, 2000. ,
DOI : 10.7326/0003-4819-126-5-199703010-00004
Outcome Following Thiopurine Use in Children With Ulcerative Colitis: A Prospective Multicenter Registry Study, The American Journal of Gastroenterology, vol.133, issue.5, pp.981-988, 2011. ,
DOI : 10.1053/j.gastro.2007.05.029
Azathioprine in the treatment of children with inflammatory bowel disease, The Journal of Pediatrics, vol.117, issue.5, pp.809-823, 1990. ,
DOI : 10.1016/S0022-3476(05)83349-9
Relationship Between Azathioprine Dosage and Thiopurine Metabolites in Pediatric IBD Patients, Therapeutic Drug Monitoring, vol.35, issue.2, pp.251-258, 2013. ,
DOI : 10.1097/FTD.0b013e318282c3a6
URL : https://hal.archives-ouvertes.fr/hal-01324627
Role of Thiopurine Metabolite Testing and Thiopurine Methyltransferase Determination in Pediatric IBD, Journal of Pediatric Gastroenterology and Nutrition, vol.56, issue.3, pp.333-373, 2013. ,
DOI : 10.1097/MPG.0b013e3182844705
Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis, Clinical Gastroenterology and Hepatology, vol.10, issue.4, pp.391-400, 2012. ,
DOI : 10.1016/j.cgh.2011.11.026
Outcome Following Infliximab Therapy in Children With Ulcerative Colitis, The American Journal of Gastroenterology, vol.55, issue.6, pp.1430-1436, 2010. ,
DOI : 10.1038/ajg.2009.759
Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease, Clinical Gastroenterology and Hepatology, vol.8, issue.3, pp.268-74, 2010. ,
DOI : 10.1016/j.cgh.2009.11.024
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease, New England Journal of Medicine, vol.362, issue.15, pp.1383-95, 2010. ,
DOI : 10.1056/NEJMoa0904492
The use of biologic agents in pediatric inflammatory bowel disease, Current Opinion in Pediatrics, vol.24, issue.5, pp.609-623, 2012. ,
DOI : 10.1097/MOP.0b013e3283574154
The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children, Clinical Gastroenterology and Hepatology, vol.4, issue.9, pp.1118-1141, 2006. ,
DOI : 10.1016/j.cgh.2006.04.008
Impact of Disease and Treatments on Growth and Puberty of Pediatric Patients with Inflammatory Bowel Disease, Digestion, vol.85, issue.4, pp.308-327, 2012. ,
DOI : 10.1159/000336766
Surgical treatment of chronic inflammatory bowel disease in children, Pediatric Surgery International, vol.20, issue.4, pp.385-90, 2011. ,
DOI : 10.1007/s00383-004-1232-5
Restoring the gut microbiome for the treatment of inflammatory bowel diseases, World Journal of Gastroenterology, vol.20, issue.13, pp.3468-74, 2014. ,
DOI : 10.3748/wjg.v20.i13.3468
Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab, Gastroenterology, vol.137, issue.4, pp.1250-60, 2009. ,
DOI : 10.1053/j.gastro.2009.06.061
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study, Alimentary Pharmacology & Therapeutics, vol.55, issue.2, pp.275-83, 2012. ,
DOI : 10.1136/gut.2005.090316
Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics, Inflammatory Bowel Diseases, vol.132, issue.9, pp.1641-1647, 2012. ,
DOI : 10.1053/j.gastro.2006.11.015
Inflammatory bowel disease in the United States from 1998 to 2005: has infliximab affected surgical rates?, Am Surg, vol.75, pp.976-80, 2009. ,
Consensus for Managing Acute Severe Ulcerative Colitis in Children: A Systematic Review and Joint Statement From ECCO, ESPGHAN and the Porto IBD Working Group of ESPGHAN, The American Journal of Gastroenterology, vol.53, issue.4, pp.574-88, 2011. ,
DOI : 10.1097/00005176-199901000-00013
Induction and maintenance therapy with vedolizumab, a novel biologic therapy for ulcerative colitis, Gastroenterol Hepatol, vol.10, pp.64-70, 2014. ,
Tofacitinib in active ulcerative colitis, N Engl J Med, vol.367, 2012. ,
Review article: anti-adhesion therapies for inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, vol.359, issue.Suppl. 1, pp.579-94, 2014. ,
DOI : 10.1016/S0140-6736(02)07374-9
Efficacy of methotrexate in ulcerative colitis, Inflammatory Bowel Diseases, vol.16, issue.8, pp.1421-1451, 2010. ,
DOI : 10.1097/00042737-200409000-00018
Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center ,
Gut Microbiota in Inflammatory Bowel Disease, Pediatric Gastroenterology, Hepatology & Nutrition, vol.16, issue.1, pp.17-21, 2013. ,
DOI : 10.5223/pghn.2013.16.1.17
Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohn??s Disease, and Pouchitis, Inflammatory Bowel Diseases, vol.96, issue.3, pp.21-35, 2014. ,
DOI : 10.1111/j.1572-0241.2001.04139.x
Safety, Tolerability, and Clinical Response After Fecal Transplantation in Children and Young Adults With Ulcerative Colitis, Journal of Pediatric Gastroenterology and Nutrition, vol.56, issue.6, pp.597-601, 2013. ,
DOI : 10.1097/MPG.0b013e318292fa0d
Morbidity of juvenile onset inflammatory bowel disease: effects on education and employment in early adult life., Gut, vol.35, issue.5, pp.665-673, 1994. ,
DOI : 10.1136/gut.35.5.665
Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.133, issue.4, pp.789-99, 2013. ,
DOI : 10.1053/j.gastro.2007.08.001
European evidence based consensus for endoscopy in inflammatory bowel disease, Journal of Crohn's and Colitis, vol.90, issue.Suppl. 1, pp.982-1018, 2013. ,
DOI : 10.1002/bjs.4007
Mise au point??: ??volution des indications de la coloscopie chez l???enfant en 2012, Archives de P??diatrie, vol.19, issue.11, pp.1247-51, 2012. ,
DOI : 10.1016/j.arcped.2012.08.005
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, vol.55, issue.6, pp.749-53, 2006. ,
DOI : 10.1136/gut.2005.082909
Food Allergies and Eosinophilic Gastrointestinal Illness, Gastroenterology Clinics of North America, vol.36, issue.1, pp.75-91, 2007. ,
DOI : 10.1016/j.gtc.2007.01.003
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis, Journal of Hepatology, vol.31, issue.5, pp.929-967, 1999. ,
DOI : 10.1016/S0168-8278(99)80297-9
Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management, Gastroenterology, vol.145, issue.3, pp.521-557, 2013. ,
DOI : 10.1053/j.gastro.2013.06.052
Review of the diagnosis, classification and management of autoimmune pancreatitis, World J Gastrointest Pathophysiol, vol.5, pp.71-81, 2014. ,
New serological markers in pediatric patients with inflammatory bowel disease, World Journal of Gastroenterology, vol.20, issue.17, pp.4873-82, 2014. ,
DOI : 10.3748/wjg.v20.i17.4873
Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?, European Journal of Gastroenterology & Hepatology, vol.8, issue.11, pp.1095-100, 1996. ,
DOI : 10.1097/00042737-199611000-00012
Pediatric ???PSC-IBD???: A Descriptive Report of Associated Inflammatory Bowel Disease Among Pediatric Patients With PSC, Journal of Pediatric Gastroenterology and Nutrition, vol.33, issue.3, pp.296-300, 2001. ,
DOI : 10.1097/00005176-200109000-00013
Future directions in inflammatory bowel disease management, Journal of Crohn's and Colitis, vol.5, issue.Suppl. 2, pp.726-760, 2014. ,
DOI : 10.1371/journal.pone.0013085
Etude comparative rétrospective sur les RCH de l'enfant associées ou non à des maladies auto-immunes", ne relève pas du champ d'application de la loi sur les recherches biomédicales portant sur la personne humaine ,